tiprankstipranks
Kazia Therapeutics trading halted, news pending
PremiumThe FlyKazia Therapeutics trading halted, news pending
28d ago
Kazia Therapeutics Adjusts ADS Ratio to Boost Nasdaq Listing
Premium
Company Announcements
Kazia Therapeutics Adjusts ADS Ratio to Boost Nasdaq Listing
1M ago
Kazia Therapeutics Reveals Promising Brain Cancer Study
Premium
Company Announcements
Kazia Therapeutics Reveals Promising Brain Cancer Study
2M ago
Kazia Therapeutics executes licensing agreement with QIMR Berghofer Medical
PremiumThe FlyKazia Therapeutics executes licensing agreement with QIMR Berghofer Medical
2M ago
Kazia Therapeutics files to sell $100M of American Depositary Shares
Premium
The Fly
Kazia Therapeutics files to sell $100M of American Depositary Shares
3M ago
Kazia’s Paxalisib Shows Potential in Glioblastoma Trial
Premium
Company Announcements
Kazia’s Paxalisib Shows Potential in Glioblastoma Trial
5M ago
Kazia Therapeutics reports 180-day extension granted by Nasdaq
PremiumThe FlyKazia Therapeutics reports 180-day extension granted by Nasdaq
6M ago
Kazia Therapeutics Granted Nasdaq Compliance Extension
Premium
Company Announcements
Kazia Therapeutics Granted Nasdaq Compliance Extension
6M ago
Kazia Therapeutics’ EVT801 Phase 1 clinical trial completes Phase 1 objectives
Premium
The Fly
Kazia Therapeutics’ EVT801 Phase 1 clinical trial completes Phase 1 objectives
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100